Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a Pre-Transplant HPV shot protect patients after surgery?

NCT ID NCT03036930

First seen Jan 05, 2026 · Last updated May 24, 2026 · Updated 26 times

Summary

This study looks at whether giving the HPV vaccine to adults before they receive a kidney transplant can help their bodies build a strong immune response. After transplant, patients take drugs to prevent rejection, which weaken the immune system. The goal is to see if the vaccine still works to protect against HPV-related cancers in this vulnerable group. About 51 participants will receive the vaccine before their scheduled transplant.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMAVIRUS INFECTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Cedars-Sinai Medical Center

    Los Angeles, California, 90048, United States

  • Mayo Clinic in Rochester

    Rochester, Minnesota, 55905, United States

  • Northwestern University

    Chicago, Illinois, 60611, United States

  • UCSF Medical Center-Mount Zion

    San Francisco, California, 94115, United States

  • UNC Lineberger Comprehensive Cancer Center

    Chapel Hill, North Carolina, 27599, United States

  • University of Alabama at Birmingham Cancer Center

    Birmingham, Alabama, 35233, United States

Conditions

Explore the condition pages connected to this study.